Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study

Background: German authorities reimburse migraine prevention with erenumab only in patients who previously did not have therapeutic success with at least five oral prophylactics or have contraindications to such. In this real-world analysis, we assessed treatment response to erenumab in patients wit...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Neurol
Main Authors: Raffaelli, Bianca, Kalantzis, Rea, Mecklenburg, Jasper, Overeem, Lucas Hendrik, Neeb, Lars, Gendolla, Astrid, Reuter, Uwe
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Neurology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7270347/
https://ncbi.nlm.nih.gov/pubmed/32547474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00417
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker